Events, conditions, episodes project group activities Bruce Goldberg, MD, PhD.

Slides:



Advertisements
Similar presentations
Testing Relational Database
Advertisements

Study Designs in Epidemiologic
Introduction to Epidemiology
Project management Project manager must;
 The most frequent forms of inherited thrombocytopenia (IT) are characterized by platelet size abnormalities and it has been suggested that this parameter.
Recheck Examinations and Results Of course it’s hard. That’s what makes it difficult.
Research Methods in MIS
© 2005 Prentice Hall4-1 Stumpf and Teague Object-Oriented Systems Analysis and Design with UML.
Scientific method - 1 Scientific method is a body of techniques for investigating phenomena and acquiring new knowledge, as well as for correcting and.
Copyright © 2001 College of American Pathologists Sample Hierarchy for Hepatitis Chronic viral hepatitis Chronic viral hepatitis C About SNOMED Relationships.
MUTATIONS AND GENETIC DISEASES PART 4. V. GENETIC CONDITIONS 1.Genetic Abnormality – rare condition with little or no ill effects - Ex. Six fingers, albino,
Shortness of Breath Abdulrahman Al Frayh Professor of Pediatrics Consultant Pediatric Pulmonologist King Saud University.
Discussion Gitanjali Batmanabane MD PhD. Do you look like this?
The Nature of Disease.
These slides are designed to accompany Software Engineering: A Practitioner’s Approach, 7/e (McGraw-Hill 2009). Slides copyright 2009 by Roger Pressman.1.
Severity Index for patients with Liver Cirrhosis disease Health Decision Analysis Yokabid Worku
Serbia Health Project – Additional Financing Training for Trainers on AR-DRG, Република Србија МИНИСТАРСТВО ЗДРАВЉА Linda Best
EVAL 6970: Cost Analysis for Evaluation Dr. Chris L. S. Coryn Nick Saxton Fall 2014.
Concept Model for observables, investigations, and observation results For the IHTSDO Observables Project Group and LOINC Coordination Project Revision.
ADVERSE EFFECTS OF DRUGS Phase II May Adverse Drug Reaction An adverse reaction to a drug is a harmful or unintended response. ADRs are claimed.
Study Designs in Epidemiologic
Research Study Design. Objective- To devise a study method that will clearly answer the study question with the least amount of time, energy, cost, and.
PM2.5 Model Performance Evaluation- Purpose and Goals PM Model Evaluation Workshop February 10, 2004 Chapel Hill, NC Brian Timin EPA/OAQPS.
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
1 Copyright © 2011 by Saunders, an imprint of Elsevier Inc. Chapter 8 Clarifying Quantitative Research Designs.
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
The Guilty, the Innocent, and the SNOMED Shuffle Attributes in transition.
IHTSDO Editorial Advisory Group James T. Case Head of Terminology.
© University of Manchester Creative Commons Attribution-NonCommercial 3.0 unported 3.0 license Lexically Suggest, Logically Define: QA of Qualifiers &
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
1 Lecture 15: Chapter 19 Testing Object-Oriented Applications Slide Set to accompany Software Engineering: A Practitioner’s Approach, 7/e by Roger S. Pressman.
 True or False 1.A person’s chances of developing a hereditary disease are determined only by his or her genes 2.The Human Genome Project has allowed.
SNOMED mapping for Pan-Canadian Surgery Templates Elaine Maloney January 27, 2015 ITHSDO Implementation SIG.
Anne Casey Chair, IHTSDO Nursing SIG. Issues Synonymous terms? Whether or not synonymous : inconsistent application – mainly in procedures but also in.
Error Tolerance HN Accounting Network Event 1 March 2011.
Company LOGO. Company LOGO PE, PMP, PgMP, PME, MCT, PRINCE2 Practitioner.
Title, Edition ISBN © 2009 Pearson Education, Inc. All rights reserved. Exceptional Children: An Introduction to Special Education, 9th Edition ISBN X.
Editorial Advisory Group IHTSDO Business Meeting London April 2016 James T. Case Head of Terminology.
Finding Content in SNOMED CT Jo Oakes – Knowledge & Information Manager.
Introduction to Pathology And its rule in the diagnostic process Dr. Atif Ali Bashir, MD Pathology Assistant Professor College of Medicine Majma’ah University.
Microorganism Name changes IHTSDO Business Meetings Content Advisory Group April 2016 London, England.
Characterstic of disease
S. aureus subtypes based on Methicillin resistance
Representation of Hypersensitivity and Allergy in SNOMED CT
Representation of Hypersensitivity, Allergy and adverse reactions in SNOMED CT Bruce Goldberg, MD, PhD.
Representation of Hypersensitivity and Allergy in SNOMED CT
Monogenic Disorders Genetic Counselling
Addition of during, during AND/OR after to associated with role hierarchy Original goal of project was to develop model for intraoperative complications.
Scope The scope of this test is to make a preliminary assessment of the fitness of the Draft Observables and Investigation Model (Observables model)
Update on ongoing issues with ECE
Original model Disorder to allergic reaction Allergic state
February 17, 2017 Bruce Goldberg, MD, PhD
Drug and Substance Project Update
Drug and Substance Project Update
Observable entities and Clinical findings
Allergy Topics.
Complications and sequelae update
Hypersensitivity dispositions as clinical findings
Software Requirements analysis & specifications
Regulatory perspective
Chapter 24 Testing Object-Oriented Applications
A bit more about Read Codes and SNOMED CT
Chapter 19 Testing Object-Oriented Applications
Pima Medical Institute Online Education
Chapter 19 Testing Object-Oriented Applications
Living Donor Committee Spring 2014
Potentially Preventable Readmissions
Living Donor Committee Spring 2014
Potentially Preventable Readmissions
Interpreting Epidemiologic Results.
Presentation transcript:

Events, conditions, episodes project group activities Bruce Goldberg, MD, PhD

▪Update the editorial guide to clarify the decision process for assigning the various modeling patterns for combined disorders ▪Develop a rigorous testing approach to evaluate the combined disorder model ▪Introduce additional temporal intervals/sequences to SNOMED CT using new roles or expanding the range of values for existing roles with respect to combined disorders and procedure complications ▪Develop a plan for retrospectively remediating existing combined disorder content ▪Address complex combined disorders (>2 conditions) ▪Update allergy model ▪Review model for allergic condition (due to allergic reaction) ▪Add allergic condition and autoimmune disorder under |Disorder of immune function (disorder)| ▪Add new classes of adverse sensitivity and intolerance ECE Goals – 2016 and onward

▪Guidelines for modeling combined disorder patterns ▪Addition of during, during AND/OR after to associated with role hierarchy ▪Application of ECE guidance retrospectively - maintenance of existing descriptions that may be ambiguous ▪Syndromes in which constituent conditions are variably present Current discussions

▪Current model for combined disorders is based on time intervals (co-occurrence, following) and causality ▪Interpretation of causality and time interval between two related disorders proving to be difficult even using a very liberal definition of causality (indirect as well as direct), leading to violation of the reproducibility rule Guidelines for modeling combined disorder patterns

ConceptCausation BGCausation ECRole BGRole EC |Periodontitis co-occurrent with leukemia (disorder)|Indirect Co-occurrent and due to |Sinusitis co-occurrent with nasal polyps (disorder)|NoneIndirectCo-occurrentCo-occurrent and due to |Hematuria co-occurrent and due to cystitis (disorder)|DirectIndirectCo-occurrent and due to |Gingivitis co-occurrent with diabetes mellitus (disorder)|Indirect Co-occurrent and due to |Albinism co-occurrent with hematologic disorder (disorder)|None Co-occurrent |Varicose veins of lower limb co-occurrent with edema (disorder)|IndirectNoneCo-occurrent and due toCo-occurrent |Acute bronchitis co-occurrent with bronchiectasis (disorder)|NoneIndirectCo-occurrentCo-occurrent and due to |Pulmonary emphysema co-occurrent with fibrosis of lung (disorder)|None Co-occurrent |Mild persistent asthma co-occurrent with allergic rhinitis (disorder)|None Co-occurrent |Major laceration of heart co-occurrent with hemopericardium (disorder)|Direct due toCo-occurrent and due to |Dementia co-occurrent with human immunodeficiency virus infection (disorder)|Indirect Co-occurrent and due to |Optic atrophy associated with retinal dystrophy (disorder)|DirectNoneCo-occurrent and due toCo-occurrent |Anemia associated with acquired immunodeficiency syndrome (disorder)|Indirect Co-occurrent and due to |Dementia associated with alcoholism (disorder)|Indirect Co-occurrent and due to |Glaucoma associated with ocular trauma (disorder)|DirectIndirectdue toafter |Pericarditis associated with severe chronic anemia (disorder)|Indirect Co-occurrent and due to |Myasthenia gravis associated with thymoma (disorder)|Indirect Co-occurrent and due todue to |Skin ulcer associated with diabetes mellitus (disorder)|Indirect Co-occurrent and due to |Platelet dysfunction associated with uremia (disorder)|Indirect Co-occurrent and due to |Dementia associated with Parkinson's Disease (disorder)|DirectNoneCo-occurrent and due toCo-occurrent |Angina associated with type II diabetes mellitus (disorder)|IndirectNoneCo-occurrent and due toCo-occurrent |Neuropathy associated with endocrine disorder (disorder)|UnknownIndirectN/Adue to |Port-wine stain associated with spinal dysraphism (disorder)|None Co-occurrent Test of reproducibility of assigning causal relationship between two disorders

▪Suggested resolution to the aforementioned issue is to assign causality and time interval based on consensus, to combined disorder concepts associated with specific domains and provide guidelines for modeling these domains in the editorial guide ▪Domains would initially represent high impact, high usage areas ▪Examples ▪Infections ▪Diabetic complications ▪AIDs related disorders ▪Additional domains to be considered based on authors input Proposed approach to achieving reproducibility for modeling combined disorders

Stated view Inferred view Infections, co-occurrence, causation, sites and morphology “Covert co-occurrence” Review of NHS GP/FP refset reveals that many concepts due to the way they are modeled with role groups, may inherit more than parent and thus be interpreted as consisting of more than one CLP which may not be apparent from the FSN Example: Infective uveitis ( may be recast as Uveitis co-occurrent and due to eye infection)

Infective (infectious) vs infected ▪Difference between infections directly resulting in a morphologically abnormal structure ( e.g. inflammation) and infections of a morphologically abnormal structure due to another cause (e.g. infected blister) and infections of a previously inflamed site (infected eczema). ▪If infections cause and occur at the same time as inflammation they should be modeled as inflammation co-occurrent and due to infection Y ▪Alternatively, if inflammation is considered to be the inevitable outcome of infections, then inflammation co- occurrent with infection Y would suffice

Standard modelling patterns (with preferred role group combinations) required for several infectious disease variants (which are currently inconsistently applied) ▪ infection (including asymptomatic carrier states) ▪ Infection at site ▪ Infection by organism ▪ Infection by organism at site ▪ Infection by organism causing morphologic abnormality ▪ Infection by organism causing morphologic abnormality at site (e.g. tuberculous ascites, infective corneal ulcer) ▪ Infection by organism in morphologic abnormality ▪ Infection by organism in morphologic abnormality at site (e.g. infected ascites, infected varicose ulcer) ▪ Infection by organism in morphologic abnormality, causing other morphologic abnormality, at site

▪FSN Patterns ▪X in diabetes ▪X of diabetes ▪X due to diabetes ▪Diabetic X ▪X associated with diabetes ▪X complication of diabetes ▪Possible modeling patterns ▪X due to diabetes ▪X co-occurrent and due to diabetes ▪Modeling pattern might be dependent upon nature of X ▪X = coma (coma co-occurrent and due to diabetes) ▪X = disorder of retina (disorder of retina due to diabetes) ▪Allows for possibility of persistence of retinal disorder after treatment of diabetes with islet cell transplant ▪Alternate approach – apply single modeling pattern (e.g. x co-occurrent and due to diabetes) to all diabetic complications ▪In the majority of cases by the time long term complications appear diabetes is chronic and incurable and will thus be necessarily present during the entire course of the complication ▪Advantage of capturing diabetes as a second parent and thus potentially increasing the documentation and reported prevalence of diabetes Diabetic complications

▪Identify domains ▪Based on frequency data of SNOMED from NHS GP/FP refset and KP CMT ▪Input from modelers (authors) ▪Develop modeling guidelines for each domain/subdomain ▪Evaluate agreed upon model in test environment ▪Update editorial guide Workplan

▪Original goal of project was to develop model for intraoperative complications ▪Model for post operative complications exists ▪Model to be extended to include not only intraoperative and postoperative complications but also perioperative complications ▪Although perioperative commonly refers to the period of time prior to, during and after surgery, in terms of perioperative complications, we considered perioperative as occurring during surgery, after surgery or a time interval beginning during surgery and continuing in the post operative period. ▪Thus intraoperative and postoperative complications would be considered subtypes of perioperative complications. ▪The preoperative period was not considered for this exercise as a complication (consequence) of surgery would not be expected to occur prior to the surgery. Addition of during, during AND/OR after to associated with role hierarchy

▪Proposed model for intraoperative complications is to approve use of |During (attribute)|with a range limited to procedures ▪Concern expressed that extending range of during to include clinical findings/disorders would overlap with the co-occurrence model for combined disorders ▪Proposed model for perioperative complication is to create a new role, during AND/OR after as a descendant of associated with and an ancestor of both during and of after ▪Above models applicable to other procedure related complications Surgical complications

Revised associated with role hierarchy

Intraoperative complication Intraoperative X or X during surgery Model X Defined concept During Surgical Procedure ≡ Complicatio n

Intraoperative complication

Injury to nerve during surgery

Injury to viscus/spleen during surgery

Intraoperative fracture

Intraoperative hemorrhage

Intraoperative complication hierarchy

Perioperative complications

Remaining issues ▪We did not consider approval of |Before (attribute)| at this time. ▪It is appreciated that additional mechanisms for representation of temporal intervals in SNOMED CT such as the use of occurrence or another role with |Temporal periods relating to physiological functions (qualifier value)| may be required in addition to before, during, during and/or after and after in order to capture other temporal relationships such as perinatal, perimenopausal and pregnancy-associated

▪An agreement with INSERM to add Orphanet rare diseases to the International release of SNOMED CT. ▪1700 rare conditions that are variably named for the primary clinical manifestations and the eponymous name of the people who identified the condition. ▪E.g. Hydrocephalus-agyria-retinal dysplasia syndrome Walker-Warburg syndrome ▪The issue with these terms is that the clinical manifestations in the name of these diseases are variably present and often not co-occurrent. Therefore, they cannot be modeled as always and necessarily being true as having those conditions. ▪Questions ▪Which term should be the FSN (eponym or clinical term) ? ▪If the latter, what is the proper structure of the FSN? Currently Orphanet uses dashes to separate the different clinical manifestations Syndromes in which constituent conditions are variably present

▪Current editorial favors expansions but ”…allow[ing exceptions] when the full description is exceptionally long and unwieldy..". ▪Follow the current guidance to use expanded forms but accepting that there is room for judgment. ▪Use eponym when commonly associated with usage ▪E.g. Tetralogy of Fallot as opposed to RVH, VSD, pulmonary artery stenosis and overriding aorta ▪On the actual form of the expanded term, don’t use the full 'co-occurrent with' connective between various components. ▪Preference is to use a comma separated list, a final 'and' and a closing 'syndrome’ ▪Eg. Hydrocephalus, agyria and retinal dysplasia syndrome' rather than 'Hydrocephalus-agyria-retinal dysplasia syndrome' simply ▪Might make parsing & word tokenization more predictable. FSN Naming

▪Building on the established genetic/congenital approach ( nital_genet_devel_acq ) many of the new additions will need modelling judgments on how they are added: nital_genet_devel_acq ▪Hereditary/genetic disorders ▪Add as primitively asserted subtypes of | Hereditary disease (disorder) ▪Congenital disorders ▪Model with occurrence=congenital General modelling

▪Model using the most suitable finding site=chromosome structure refinement and associated morphology value. ▪Example Ring chromosome 20 syndrome ▪Finding site = |Chromosome pair 20 (cell structure)| ▪Associated morphology = |Ring chromosome (morphologic abnormality)| ▪Observable model required for representing specific mutations (see e.g. artf Malignant neoplasm with gene mutation) Chromosomal abnormalities

▪The preferred approach is to identify from the experts/literature the essential/cardinal features of each named syndrome. ▪Ideally each of these can be included as a role grouped 'condition' (and thus acquires the appropriate supertype by classification), but where this is not feasible essential features can only be included by directly asserting as supertypes. ▪Variant features (e.g. encephalocele for Walker-Warburg) would not be included in the formal definition, but if important then variants that 'include' another feature can be added as subtypes of the base concept. ▪Naming convention ▪X syndrome with Y (Walker-Warburg syndrome with encephalocele) ▪For those syndromes where only a handful of 'essential/cardinal' features are included in the definition, consider an FSN of the type “X syndrome including phenotypic variants” to indicate there may well be other features but they are not included here. Specific modelling

Application of ECE guidance retrospectively - maintenance of existing descriptions that may be ambiguous ▪Presentation at Montevideo meeting outlined plan for remediating existing combined disorder content based on identifying concepts modeled with associated with and its descendants and attempting to reconcile the model with the FSN ▪Based on the current approach to providing guidelines for modeling combined disorder concepts as outlined on slide 6, we will initially concentrate on remediating content for specific high frequency, high impact domains such as infectious disease, diabetic complications, AIDS related disorders

Revised work plan ▪Identify relevant domains ▪Usage analysis of NHS GP/FP refset and KP CMT donation ▪Feedback from authors/modeling team ▪Identify naming patterns and models within each domain ▪Search for inferred parents that might indicate “covert” co- occurrence ▪Determine temporal sequence and causation ▪Apply correct model and/or FSN if required based on domain-specific guidelines to be developed